NAPPI, ROSSELLA
 Distribuzione geografica
Continente #
NA - Nord America 6.511
EU - Europa 4.522
AS - Asia 3.746
AF - Africa 29
SA - Sud America 26
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 14.853
Nazione #
US - Stati Uniti d'America 6.480
CN - Cina 3.250
IE - Irlanda 1.494
UA - Ucraina 772
FI - Finlandia 625
DE - Germania 486
IT - Italia 479
SG - Singapore 403
SE - Svezia 304
GB - Regno Unito 160
FR - Francia 76
RU - Federazione Russa 51
NL - Olanda 27
CA - Canada 25
IR - Iran 21
BR - Brasile 20
BE - Belgio 19
IN - India 17
ET - Etiopia 16
JP - Giappone 12
AU - Australia 11
ES - Italia 8
KR - Corea 8
HK - Hong Kong 7
EU - Europa 6
MX - Messico 6
MY - Malesia 5
PK - Pakistan 5
PT - Portogallo 5
TW - Taiwan 4
AT - Austria 3
EC - Ecuador 3
MA - Marocco 3
MU - Mauritius 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
DK - Danimarca 2
GH - Ghana 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LV - Lettonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 14.853
Città #
Dublin 1.491
Chandler 1.329
Jacksonville 1.088
Nanjing 1.007
Boardman 486
Ashburn 436
Nanchang 422
Princeton 369
Lawrence 337
Hebei 284
Shenyang 281
Singapore 274
Wilmington 273
Changsha 255
Jiaxing 234
Medford 233
Beijing 177
Tianjin 167
Helsinki 156
Ann Arbor 138
Hangzhou 137
Shanghai 91
Woodbridge 86
Milan 78
Norwalk 55
New York 45
Pavia 43
Fairfield 38
Seattle 38
Los Angeles 32
Houston 28
Verona 26
Des Moines 25
Chicago 23
Kunming 23
Munich 22
Falls Church 20
Brussels 19
Gallarate 17
Varese 17
Aksum 16
Ningbo 16
Moscow 15
Washington 15
Orange 14
Rozzano 14
Auburn Hills 13
Rome 13
Zhengzhou 13
Dallas 12
Shenzhen 12
Amsterdam 11
Florence 10
Jinan 10
Palermo 10
Taizhou 9
Toronto 9
Turin 9
Falkenstein 8
Redwood City 8
St Petersburg 8
Tehran 8
Tokyo 8
Berlin 7
Dearborn 7
Piacenza 7
Stockholm 7
Frankfurt am Main 6
Fuzhou 6
Guangzhou 6
Lanzhou 6
London 6
Padova 6
Piscataway 6
Andover 5
Changchun 5
Cusano Milanino 5
Galveston 5
Gatchina 5
Monmouth Junction 5
Montreal 5
Pune 5
Adelaide 4
Austin 4
Bologna 4
Genoa 4
Karaj 4
Menlo Park 4
Paris 4
Reston 4
Rockville 4
San Francisco 4
Shijiazhuang 4
Albinea 3
Borås 3
Brescia 3
Catania 3
Chelyabinsk 3
Chiba 3
Curitiba 3
Totale 10.736
Nome #
Cellule staminali mesenchimali da liquido follicolare ovarico umano: caratterizzazione morfologica e funzionale 226
Clinical study on the dose-effect relationship of a nifuratel-nystatin combination in the treatment of vulvo-vaginal infections 101
Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy 86
Aging and sexuality in women 84
Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity. 80
Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: The hidden role of thyroid autoimmunity 80
Sexual Function and Distress in Women Treated for PrimaryHeadaches in a Tertiary University Center. 78
Correlation between human immunodeficiencyvirus type 1 levels and cytokine profile into thecervicovaginal secretions of a female cohort 78
Management of hypoactive sexual desire disorder in women: current and emerging therapies. 78
COMPARISON OF DIFFERENT PROTOCOLS FOR HUMAN SPERM CRYOPRESERVATION: ULTRASTRUCTURAL, MOLECULAR AND CYTOMETRIC ANALYSIS 76
Dietary under-reporting in women affected by Polycystic Ovary Syndrome: A Pilot Study. 76
HPV infection inhibits aquaporin-mediated hydrogen peroxide elimination and affects human sperm function 76
Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval 75
Stress and Autonomic Nervous System 75
Aspetti dietetico nutrizionali dell'infertilità femminile 73
Aging is associated with changes in allopregnanolone concentrations in brain, endocrine glands and serum in male rats. 72
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. 71
Dietary intakes in infertile women a pilot study 71
In-vitro culture system for mesenchymal progenitor cells derived from waste human ovarian follicular fluid. 70
Acute stress- or lipopolysaccharide-induced corticosterone secretion in female rats is independent of the oestrous cycle. 69
Blood cell mitochondrial DNA content and premature ovarian aging 69
Eating disorders and Axis I psychiatric comorbidity in amenorrheic women. 69
Ontogeny of the circadian rhythm in medial basal hypothalamic beta-endorphin content in female rat. 69
Attitudes, perceptions and knowledge about the vagina: the International Vagina Dialogue Survey 68
Changes in nociceptive flexion reflex threshold across the menstrual cycle in healthy women 67
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. 67
Hormonal and psycho-relational aspects of sexual function during menopausal transition and at early menopause. 66
Migraine and reproductive life. 66
Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes 65
3-D volumetric and vascular analysis of the urethrovaginal space in young women with or without vaginal orgasm. 65
Effects of an estrogen-free, desogestrel-containing oralcontraceptive in women with migraine with aura: a prospective diary-based pilotstudy. 65
VULVODYNIA, VULVAR VESTIBULITIS: ETIOLOGY, DIAGNOSIS AND CLINICAL EVALUATION 64
Role of testosterone in feminine sexuality 63
Psychoneuroendocrine correlates of secondary amenorrhea 63
Hormonal management of migraine at menopause. 63
Cognitive function at menopause: neuroendocrine implications for the study of the aging brain. 63
Advances in pharmacotherapy for treating female sexual dysfunction 63
Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. 62
Effects of surgical and adjuvant therapies for breast cancer on sexuality,cognitive functions, and body weight. 62
Effect of immune and metabolic challenges on the luteinizing hormone-releasing hormone neuronal system in cycling female rats: an evaluation at the transcriptional level. 62
Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. 62
Electrical stimulation (ES) in the management of sexual pain disorders 62
PCOS and urethrovaginal space: 3-D volumetric and vascular analysis. 61
Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. 61
Robotic single site hysterectomy with bilateral salpingo-oophorectomy in female to male transsexualism. 61
New attitudes to sexuality in the menopause: clinical evaluation and diagnosis 60
Association of E2v/dng as contraceptive choice for a better quality of life of women. 60
Effects of combined hormonal contraception on health and wellbeing: Women's knowledge in northern Italy. 60
A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure. 60
Clitoral artery blood flow in healthy young women: preliminary report on menstrual cycle and hormonal contraception 60
Neuroendocrine findings in chornic paroxysmal hemicrania and hemicrania continua 59
Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease. 59
Reproductive life milestones in women with Parkinson's disease 58
Involvement of mu-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats. 58
Bone mass and long-term monophasic oral contraceptive treatment in young women. 58
Follicular fluid putative mesenchymal stem cells (FF-MSC) release E2 and P in vitro 58
The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy. 58
Evidence for a role of neurosteroids in modulation of diurnal changes and acute stress-induced corticosterone secretion in rats. 58
Neurobiologia della risposta di stress. 58
Emicrania e ormoni gonadici femminili:implicazioni per il sistema nervoso centrale. 58
Effect of local estrogen therapy (LET) on urinary and sexual symptoms in premenopausal women with interstitial cystitis/bladder pain syndrome (IC/BPS) 58
Use of the Italian translation of the Female Sexual Function Index (FSFI) in routine gynecological practice. 58
Time for a consensus conference on pain in neurorehabilitation 58
Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres 57
Endocrine aspects of women's sexual function. 57
Course of primary headaches during hormone replacement therapy. 57
Cigarette smoking decreases the genital vascularization in younghealthy, eumenorrheic women. 57
Counseling and management of patients requesting subcutaneous contraceptive implants: proposal for a decisional algorithm. 57
Aging female brain: is there a change of adaptive stress? 57
External cephalicversion as a possible treatment of breech presentation 57
Sexual function and endocrine profile in fertile women with type 1 diabetes 56
Ultrasonographic and Doppler findings of subclinical clitoral microtraumatisms inmountain bikers and horseback riders. 56
Female sexual dysfunction is more than just a hormonal problem. 56
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian consensus conference on pain in neurorehabilitation 56
Migraine is a risk factor for hypertensive disorders inpregnancy: a prospective cohort study. 55
The neuroendocrine effects of sumatriptan, a specific ligand for 5-HT1-like receptors. 55
Perineal floor efficiency in sexually potent and impotent men. 55
Novel regulators of the in vitro release of corticotrophin-releasing hormone two decades after its discovery: a review 55
SEXUAL FUNCTION IN WOMEN WITH INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME 55
Vaginal health in the United States 55
Parkinson's disease and reproductive life events 54
Menopause and sexual desire: the role of testosterone. 54
The impact of the mid-urethral slings for the treatment of stress urinaryincontinence on female sexuality. 54
Pituitary LH reserve suggests high risk of bulimia in amenorrheic women. 54
Nerve-sparing approach reduces sexual dysfunction in patients undergoing laparoscopic radical hysterectomy. 54
Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature. 54
Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. 54
The role of 3-D ultrasonography in the evaluation of menstrual cycle-related vascularmodifications of the clitoris. A prospective pilot study. 53
Oral magnesium successfully relieves premenstrual mood changes. 53
The CLOSER survey: Impact of postmenopausal vaginal discomfort on relationships between women and their partners in Northern and Southern Europe 53
Hormonal contraception in women with migraine: is progestogen-only contraception a better choice? 53
The brain as a target organ of gonadal steroids. 53
ULTRASTRUCTURAL FEATURES OF HUMAN SPERM CELLS CRYOPRESERVED BY DIFFERENT METHODS 53
Oral D-mannose in recurrent urinary tract infections in women: A pilot study 53
Modulation of nociceptive threshold by combined hormonal contraceptives in women with oestrogen-withdrawal migraine attacks: a pilot study 53
Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics? 53
Adrenergic and serotoninergic receptors mediate the immunological activation of corticosterone secretion in male rats. 53
Different effects of tibolone and low-dose EPT in the management of postmenopausal women with primary headaches 52
Recommendations for the management of postmenopausal vaginal atrophy. 52
Sexual dysfunction in obese women: Does obstructive sleep apnea play a role? 52
Totale 6.376
Categoria #
all - tutte 73.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020539 0 0 0 0 0 0 21 162 7 216 128 5
2020/20211.586 171 132 61 162 13 202 11 285 74 232 197 46
2021/20221.249 13 9 17 12 19 22 23 75 87 36 217 719
2022/20234.132 506 269 28 275 444 416 4 234 1.758 24 129 45
2023/20241.473 162 251 66 140 174 318 73 101 16 55 55 62
2024/20251.188 115 417 106 175 94 262 19 0 0 0 0 0
Totale 15.317